3-Amino-1-alkyl-cyclopentane carboxamides as small molecule antagonists of the human and murine CC chemokine receptor 2

被引：30

作者：

Butora, Gabor ^{[1
]}

Jiao, Richard ^{[1
]}

Parsons, William H. ^{[1
]}

Vicario, Pasquale P. ^{[1
]}

Jin, Hong ^{[1
]}

Ayala, Julia M. ^{[1
]}

Cascieri, Margaret A. ^{[1
]}

Yang, Lihu ^{[1
]}

机构：

[1] Merck Res Labs, Rahway, NJ 07065 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 13期

关键词：

D O I：

10.1016/j.bmcl.2007.04.053

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of low molecular weight antagonists of both the human and murine CC chemokine receptor 2, containing a l-alkyl-3-(3-methyl-4-spiroindenylpiperidine)-substituted cyclopentanecarboxamide, is described. A SAR study of the C, substituent revealed that short, branched alkyl groups such as isopropyl, isobutyl, or cyclopropyl are optimal for both human and murine CCR2 binding activity. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：3636 / 3641

页数：6

共 30 条

[1] Serum-induced monocyte differentiation and monocyte chemotaxis are regulated by the p38 MAP kinase signal transduction pathway
Ayala, JM
Goyal, S
Liverton, NJ
Claremon, DA
O'Keefe, SJ
Hanlon, WA
[J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2000, 67 (06) : 869 - 875
[2] A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
Baba, M
Nishimura, O
Kanzaki, N
Okamoto, M
Sawada, H
Iizawa, Y
Shiraishi, M
Aramaki, Y
Okonogi, K
Ogawa, Y
Meguro, K
Fujino, M
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) : 5698 - 5703
[3] Chemokines: more than just road signs
Bachmann, MF
Kopf, M
Marsland, BJ
[J]. NATURE REVIEWS IMMUNOLOGY, 2006, 6 (02) : 159 - 164
[4] Boring LF, 1998, CIRCULATION, V98, P309
[5] 4-amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties
Butora, Gabor
Morriello, Gregori J.
Kothandaraman, Shankaran
Guiadeen, Deodialsingh
Pasternak, Alexander
Parsons, William H.
MacCoss, Malcolm
Vicario, Pasquale P.
Cascieri, Margaret A.
Yang, Lihu
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (18) : 4715 - 4722
[6] Chemokines in the pathogenesis of vascular disease
Charo, IF
Taubman, MB
[J]. CIRCULATION RESEARCH, 2004, 95 (09) : 858 - 866
[7] Dawson J, 2003, EXPERT OPIN THER TAR, V7, P35
[8] CCR2B receptor antagonists: Conversion of a weak HTS hit to a potent lead compound
Forbes, IT
Cooper, DG
Dodds, EK
Hickey, DMB
Ife, RJ
Meeson, M
Stockley, M
Berkhout, TA
Gohil, J
Groot, PHE
Moores, K
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (16) : 1803 - 1806
[9] An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model
Gong, JH
Ratkay, LG
Waterfield, JD
ClarkLewis, I
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) : 131 - 137
[10] MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B
Gosling, J
Slaymaker, S
Gu, L
Tseng, S
Zlot, CH
Young, SG
Rollins, BJ
Charo, IF
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (06) : 773 - 778

← 1 2 3 →